• Journal Article

HIV prevalence and risk among heterosexual methamphetamine injectors in California

Citation

Kral, A., Lorvick, J., Martinez, A., Lewis, M., Orr, W. A., Anderson, R., ... Bluthenthal, R. N. (2011). HIV prevalence and risk among heterosexual methamphetamine injectors in California. Substance Use and Misuse, 46(9), 1081-1089. DOI: 10.3109/10826084.2011.557136

Abstract

This study funded by Centers for Disease Control compares HIV prevalence and risk behavior among heterosexual methamphetamine (n = 428) and nonmethamphetamine (n = 878) injectors in California, USA, during 2001–2003. While HIV was not highly prevalent among methamphetamine injectors (3%), sexual and injection risk behaviors were highly prevalent (ranging from 21% to 72%). In multivariate analyses, methamphetamine injectors had higher odds than nonmethamphetamine injectors of unprotected vaginal intercourse and sex with five or more sexual partners in the past 6 months and of distributive and receptive syringe sharing in the past 30 days. There was no significant difference in HIV sero-status by methamphetamine use. Suggestions are made for designing HIV prevention programs. The study's limitations are noted.